Results 161 to 170 of about 8,068 (220)

Response to SARS-CoV-2 Infection in Sjögren Syndrome Can Be Complicated by Myelitis and Guillain-Barré Syndrome. [PDF]

Intern Med
Funakoshi T, Yamada M, Ikeda K, Yokokawa K, Saito T, Tsuda R, Iwahara N, Suzuki S, Hisahara S.   +8 more
europepmc   +1 more source

Rapidly Progressive Guillain-Barré Syndrome (GBS) as a Critical Predictor of Early Mechanical Ventilation and Prolonged Hospitalization: An Observational Study at a Tertiary Care Hospital. [PDF]

Cureus
Maharjan A, Devkota M, Bishokarma S, Kharel G, Pakhrin PS, Shrestha S.   +5 more
europepmc   +1 more source

Controversies in the diagnosis of chronic inflammatory demyelinating polyneuropathy. [PDF]

Curr Opin Neurol
Doneddu PE, Fasano C, Lozi C, Marenna G, Nobile-Orazio E.   +4 more
europepmc   +1 more source

Characterizing Treatment Patterns and Healthcare Use in Patients and Subgroups with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Real-World Study. [PDF]

Neurol Ther
Hartung HP, Atassi N, Alonso-Alonso M, Nunez M, Seluzhytsky A, Smolkina E, Dormont F, Lopez-Grancha M, Saeed O, Nguyen M, Lewis R.   +10 more
europepmc   +1 more source

Mitochondrial neurogastrointestinal encephalomyopathy mimicking chronic inflammatory demyelinating polyradiculoneuropathy

Arquivos de Neuro-Psiquiatria, 2012
Camila Pupe, Osvaldo J. M. Nascimento, Giseli Quintanilha, Marcos R. G.de Freitas, Eduardo Uchôa, André P. C. Matta, João Gabriel Dib, Tânia Escada   +7 more
doaj  

Chronic inflammatory demyelinating polyradiculoneuropathy.

JPMA. The Journal of the Pakistan Medical Association, 1992
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy

New England Journal of Medicine, 2016
This letter reports two cases of severe demyelinating polyradiculoneuropathy after treatment with pembrolizumab, a humanized antibody against programmed cell death 1 receptor, for advanced melanoma.
Philippe Saiag
exaly   +2 more sources

MERCAPTOPURINE IN POLYRADICULONEUROPATHY

Lancet, The, 1966
Ingrid Gamstorp, Sidney Aronsson, Bertil Lindquist   +2 more
exaly   +2 more sources

Diabetic lumbosacral polyradiculoneuropathies

Current Treatment Options in Neurology, 2001
The pathogenic basis and treatment of diabetic polyradiculoneuropathy is a source of recent controversy as there may be two or more distinct forms of diabetic polyradiculoplexopathy. We believe that the following two categories of diabetic polyradiculoneuropathy can be made on the basis of clinically differences: 1) the more common asymmetric, painful ...
Anthony A., Amato, Richard J., Barohn
openaire   +2 more sources